Pages that link to "Q39293549"
Jump to navigation
Jump to search
The following pages link to Anterior gradient 2 (AGR2): blood-based biomarker elevated in metastatic prostate cancer associated with the neuroendocrine phenotype. (Q39293549):
Displaying 23 items.
- A highly sensitive targeted mass spectrometric assay for quantification of AGR2 protein in human urine and serum (Q24307894) (← links)
- AGR3 in breast cancer: prognostic impact and suitable serum-based biomarker for early cancer detection (Q35432936) (← links)
- Expression of AGR2 in pituitary adenomas and its association with tumor aggressiveness (Q36335461) (← links)
- Comparative Transcriptome Analysis Identifies CCDC80 as a Novel Gene Associated with Pulmonary Arterial Hypertension (Q36973719) (← links)
- Bladder cancer cells secrete while normal bladder cells express but do not secrete AGR2. (Q37085875) (← links)
- AGR2 promotes the proliferation, migration and regulates epithelial-mesenchymal transition in salivary adenoid cystic carcinoma (Q37685245) (← links)
- Circulating nucleic acids as biomarkers of prostate cancer. (Q38165244) (← links)
- Targeting neuroendocrine prostate cancer: molecular and clinical perspectives (Q38362686) (← links)
- Bioorthogonal Labeling of Human Prostate Cancer Tissue Slice Cultures for Glycoproteomics (Q38709426) (← links)
- Mechanotransduction-Induced Reversible Phenotypic Switching in Prostate Cancer Cells (Q38709756) (← links)
- Emerging trends in the evaluation and management of small cell prostate cancer: a clinical and molecular perspective. (Q38930155) (← links)
- N-acetyl-L-aspartyl-L-glutamate peptidase-like 2 is overexpressed in cancer and promotes a pro-migratory and pro-metastatic phenotype (Q39062377) (← links)
- Regulation of AGR2 expression via 3'UTR shortening (Q51059812) (← links)
- Identification, characterization and application of a new peptide against anterior gradient homolog 2 (AGR2). (Q55233846) (← links)
- Tissue proteomics outlines AGR2 AND LOX5 as markers for biochemical recurrence of prostate cancer (Q60051002) (← links)
- Circulating tumor cells mirror bone metastatic phenotype in prostate cancer (Q90403109) (← links)
- Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis (Q90695386) (← links)
- Extracellular AGR3 regulates breast cancer cells migration via Src signaling (Q90705714) (← links)
- AGR2, a unique tumor-associated antigen, is a promising candidate for antibody targeting (Q91866534) (← links)
- Circulating tumour cell RNA characterisation from colorectal cancer patient blood after inertial microfluidic enrichment (Q91867645) (← links)
- Gene Expression Alterations during Development of Castration-Resistant Prostate Cancer Are Detected in Circulating Tumor Cells (Q92255638) (← links)
- Improved early detection of ovarian cancer using longitudinal multimarker models (Q92643944) (← links)
- Circulating Tumor Cell Enumeration and Characterization in Metastatic Castration-Resistant Prostate Cancer Patients Treated with Cabazitaxel (Q92753431) (← links)